You are currently viewing Global Aortic Valve Replacement Market Size, Share, Report and Forecast 2024-2032

Global Aortic Valve Replacement Market Size, Share, Report and Forecast 2024-2032

The global aortic valve replacement market size was valued at USD 11.2 billion in 2023, driven by the rising prevalence of cardiovascular diseases across the globe. The market size is anticipated to grow at a CAGR of 12.1% during the forecast period of 2024-2032 to achieve a value of USD 31.3 billion by 2032.

Aortic Valve Replacement: Introduction

Aortic valve replacement is a surgical procedure that involves replacing a damaged or malfunctioning aortic valve in the heart with an artificial valve. The aortic valve controls the flow of blood from the left ventricle to the aorta, and when it doesn’t function properly due to conditions like aortic stenosis or regurgitation, it can lead to heart problems. During the surgery, the chest is opened, and the faulty valve is removed, and then replaced with a mechanical or bioprosthetic valve. Aortic valve replacement restores normal blood flow and helps relieve symptoms like chest pain, shortness of breath, and fatigue, ultimately improving the patient’s heart function and overall quality of life.

Get a Free Sample Report with Table of Contents – https://www.expertmarketresearch.com/reports/aortic-valve-replacement-market/requestsample

Key Trends in the Global Aortic Valve Replacement Market

TAVR, a minimally invasive procedure, has gained significant traction. Its adoption has increased due to advantages such as reduced recovery time, the possibility of treating high-risk patients who aren’t suitable for open-heart surgeries, and improved patient outcomes. Continuous innovations in valve design, materials, and delivery systems have led to more effective and durable replacement options. Enhanced imaging techniques, like 3D imaging, are aiding surgeons in precise valve placement and better pre-operative planning.

Initially, TAVR was only recommended for patients at high risk for surgical AVR. However, with accumulating evidence of its efficacy and safety, TAVR’s use has expanded to intermediate and, in some cases, low-risk patients. The global rise in the elderly population has resulted in an increased prevalence of degenerative valve diseases. This demographic shift is driving the demand for valve replacement procedures.

Favorable reimbursement scenarios, especially in developed markets like the US and Europe, have facilitated the adoption of advanced valve replacement procedures. However, the high cost of TAVR devices and procedures can be a limiting factor in certain regions. While bioprosthetic (or tissue) valves are favored due to their lack of requirement for lifelong anticoagulation, they have limitations like potential degeneration over time. Research is ongoing to improve the durability and longevity of these valves.

The integration of cath labs with operating rooms to form hybrid ORs is on the rise. These hybrid setups allow for greater flexibility in performing both surgical and transcatheter interventions, providing an optimal environment for complex procedures. There’s an emphasis on collecting long-term data and conducting clinical trials to better understand the durability, patient outcomes, and potential complications of both surgical AVR and TAVR.

Read Full Report with Table of Contents – https://www.expertmarketresearch.com/reports/aortic-valve-replacement-market

Global Aortic Valve Replacement Market Segmentation

Market Breakup by Surgery Type 

  • Open Surgery
  • Minimally Invasive Surgery

Market Breakup by Product Type              

  • Transcatheter Aortic Valve
  • Sutureless Aortic Valve Replacement (SUAVR)

Market Breakup by End User 

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 Global Aortic Valve Replacement Market Overview

North America holds a significant share of the global AVR market, primarily driven by the US. High prevalence of cardiovascular diseases, advanced healthcare infrastructure, rapid adoption of innovative technologies like Transcatheter Aortic Valve Replacement (TAVR), and favorable reimbursement scenarios contribute to the market growth.

Europe is a major player in the AVR market, with countries like Germany leading in TAVR procedures. The region’s advanced healthcare system, extensive research and development activities, an aging population with a high incidence of heart valve diseases, and supportive regulatory policies contribute to its robust market.

The APAC region has been experiencing rapid growth in the AVR market, albeit from a smaller base compared to the western markets. Factors include increasing healthcare expenditure, improving healthcare infrastructure, a growing middle-class population demanding better healthcare, and increasing awareness of advanced treatment options. However, cost concerns and limited access in some areas might hinder growth.

The market in Latin America is growing, but it might be slower than in APAC or North America. Increasing urbanization, better healthcare infrastructure in key countries, and growing awareness of heart diseases drive the demand. However, economic disparities and uneven access to advanced medical care can pose challenges.

The AVR market in MEA is relatively smaller compared to other regions but has potential for growth, particularly in affluent Gulf countries. While there’s a rising demand for advanced healthcare in wealthy Middle Eastern nations, the broader African region faces challenges like limited healthcare infrastructure, economic constraints, and lower awareness levels.

Global Aortic Valve Replacement Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

  • Boston Scientific Corporation
  • LivaNova PLC
  • Edwards Lifesciences Corporation
  • Medtronic
  • CryoLife, Inc.
  • Abbott
  • JenaValve Technology, Inc.
  • Micro Interventional Devices
  • Braile Biomedica

About Us

Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.

Our high-quality, data-driven analyses provide the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today’s competitive market.

Don’t miss the opportunity to elevate your business intelligence and fortify your strategic planning. Secure your organization’s future success by acquiring one of our Expert Market Research reports today.

Media Contact:

Company Name: Claight Corporation
Contact Person: Joe Goldberg, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA

 

Expert Market Research

Expert Market Research is a leading business intelligence firm, providing custom and syndicated market reports along with consultancy services for our clients. We serve a wide client base ranging from Fortune 1000 companies to small and medium enterprises. Our reports cover over 100 industries across established and emerging markets researched by our skilled analysts who track the latest economic, demographic, trade and market data globally. At Expert Market Research, we tailor our approach according to our clients’ needs and preferences, providing them with valuable, actionable and up-to-date insights into the market, thus, helping them realize their optimum growth potential. We offer market intelligence across a range of industry verticals which include Pharmaceuticals, Food and Beverage, Technology, Retail, Chemical and Materials, Energy and Mining, Packaging and Agriculture.